These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20398256)

  • 1. Molecular targeted therapies in head and neck cancer--an update of recent developments-.
    Goerner M; Seiwert TY; Sudhoff H
    Head Neck Oncol; 2010 Apr; 2():8. PubMed ID: 20398256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of molecular targeted therapy with radiation in head and neck cancer.
    Du Y; Peyser ND; Grandis JR
    Pharmacol Ther; 2014 Apr; 142(1):88-98. PubMed ID: 24280066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
    Bozec A; Peyrade F; Milano G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathways in head and neck cancer: EGFR, PI3K, and more.
    Psyrri A; Seiwert TY; Jimeno A
    Am Soc Clin Oncol Educ Book; 2013; ():246-55. PubMed ID: 23714515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axitinib in the Treatment of Head and Neck Malignancies.
    Swiecicki PL; Spector M; Worden FP
    Curr Clin Pharmacol; 2016; 11(2):72-6. PubMed ID: 27188575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC).
    Cohen RB
    Cancer Treat Rev; 2014 May; 40(4):567-77. PubMed ID: 24216225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Therapy of Head and Neck Cancer.
    Rieke DT; Klinghammer K; Keilholz U
    Oncol Res Treat; 2016; 39(12):780-786. PubMed ID: 27889751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecularly targeted therapies in head and neck cancers.
    Sawicki M; Szudy A; Szczyrek M; Krawczyk P; Klatka J
    Otolaryngol Pol; 2012; 66(5):307-12. PubMed ID: 23036118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma.
    Matta A; Ralhan R
    Head Neck Oncol; 2009 Mar; 1():6. PubMed ID: 19284526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising newer molecular-targeted therapies in head and neck cancer.
    Wang LX; Agulnik M
    Drugs; 2008; 68(12):1609-19. PubMed ID: 18681486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies in squamous cell carcinoma of the head and neck.
    Gold KA; Lee HY; Kim ES
    Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti EGFR therapy in the treatment of non-metastatic head and neck squamous cell carcinoma: The current evidence.
    Benson R; Mallick S; Julka PK; Rath GK
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):141-8. PubMed ID: 27160750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy in head and neck cancer.
    Bianchini C; Ciorba A; Pelucchi S; Piva R; Pastore A
    Tumori; 2011; 97(2):137-41. PubMed ID: 21617705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies for advanced non-small-cell lung cancer: current status and future implications.
    Custodio A; Méndez M; Provencio M
    Cancer Treat Rev; 2012 Feb; 38(1):36-53. PubMed ID: 21592673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual EGFR and COX-2 inhibition as a novel approach to targeting head and neck squamous cell carcinoma.
    Kao J; Sikora AT; Fu S
    Curr Cancer Drug Targets; 2009 Dec; 9(8):931-7. PubMed ID: 20025602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directions.
    Schmitz S; Ang KK; Vermorken J; Haddad R; Suarez C; Wolf GT; Hamoir M; Machiels JP
    Cancer Treat Rev; 2014 Apr; 40(3):390-404. PubMed ID: 24176789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond.
    Harari PM; Wheeler DL; Grandis JR
    Semin Radiat Oncol; 2009 Jan; 19(1):63-8. PubMed ID: 19028347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to EGF-R (erbB-1) and VEGF-R modulating agents.
    Dempke WCM; Heinemann V
    Eur J Cancer; 2009 May; 45(7):1117-1128. PubMed ID: 19124237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck.
    Juergens RA; Bratman SV; Tsao MS; Laurie SA; Sara Kuruvilla M; Razak AR; Hansen AR
    Cancer Treat Rev; 2017 Mar; 54():43-57. PubMed ID: 28192747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular therapy in head and neck oncology.
    Bernier J; Bentzen SM; Vermorken JB
    Nat Rev Clin Oncol; 2009 May; 6(5):266-77. PubMed ID: 19390553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.